STRUCTURE/ACTIVITY STUDIES OF NEUROSTEROID ANALOGUES

神经类固醇类似物的结构/活性研究

基本信息

  • 批准号:
    7384096
  • 负责人:
  • 金额:
    $ 33.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-08-01 至 2012-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT 1 Modulation of GABA-A or NMDA receptors underlies the anesthetic actions of most clinically used general anesthetics. In the central nervous system, enhancement of GABA-A receptor function increases inhibitory neurotransmission and inhibition of NMDA receptor function decreases excitatory neurotransmission. Anesthetic steroids enhance the actions of GABA at GABA-A receptors. Steroids containing negatively charged groups inhibit GABAergic neurotransmission. NMDA receptors are modulated, either positively or negatively, by steroids that contain negatively charged groups. Thus, understanding the actions of steroids at these receptors is important for understanding the clinical effects of the steroid class of anesthetics. The three specific aims of this project are focused on gaining new knowledge of the molecular details of the interactions of steroids with GABA-A and NMDA receptors. Synthetic chemistry will be performed to prepare novel analogues of anesthetic steroids for structure-activity relationships (SAR) studies. Electrophysiological, binding, and behavioral assayswill be used for evaluation of the compounds. Specific aim 1 addresses the importance of the steroid ring system for anesthetic steroid effects at GABA-A and NMDA receptors. In specific aim 2, anesthetic steroid analogues containing fluorescent groups will be prepared to: 1) investigate how steroids access their binding sites in the transmembrane domains of GABA-A receptors; and 2) investigate the entry and distribution of anesthetic steroids in brain cells. Specific aim 3 will investigate the molecular basis for the enantioselectivity of anesthetic steroid action at GABA-A receptors. The long term goals of this project are to use the methods of medicinal chemistry to obtain new pharmacological tools for investigationof the effects of steroids at GABA-A and NMDA receptors. Ultimately, this information could lead to the discovery of new anesthetic, anticonvulsant, anxiolytic and sedative hypnotic drugs.
项目1

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DOUGLAS F COVEY其他文献

DOUGLAS F COVEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DOUGLAS F COVEY', 18)}}的其他基金

Chemistry Core
化学核心
  • 批准号:
    10198245
  • 财政年份:
    2021
  • 资助金额:
    $ 33.99万
  • 项目类别:
Chemistry Core
化学核心
  • 批准号:
    10456976
  • 财政年份:
    2021
  • 资助金额:
    $ 33.99万
  • 项目类别:
Chemistry Core
化学核心
  • 批准号:
    10662448
  • 财政年份:
    2021
  • 资助金额:
    $ 33.99万
  • 项目类别:
Development of chemical biology tools for NMDA receptors
NMDA 受体化学生物学工具的开发
  • 批准号:
    9310158
  • 财政年份:
    2017
  • 资助金额:
    $ 33.99万
  • 项目类别:
MOLECULAR SITES OF NEUROSTEROID BINDING
神经类固醇结合的分子位点
  • 批准号:
    8610535
  • 财政年份:
    2014
  • 资助金额:
    $ 33.99万
  • 项目类别:
Signal Transduction by Oxysterols
氧甾醇的信号转导
  • 批准号:
    8920626
  • 财政年份:
    2014
  • 资助金额:
    $ 33.99万
  • 项目类别:
Signal Transduction by Oxysterols
氧甾醇的信号转导
  • 批准号:
    8694262
  • 财政年份:
    2014
  • 资助金额:
    $ 33.99万
  • 项目类别:
STRUCTURE/ACTIVITY STUDIES OF NEUROSTEROID ANALOGUES
神经类固醇类似物的结构/活性研究
  • 批准号:
    8118826
  • 财政年份:
    2010
  • 资助金额:
    $ 33.99万
  • 项目类别:
MEDICINAL CHEMISTRY OF STEROIDS
类固醇的药物化学
  • 批准号:
    7721490
  • 财政年份:
    2008
  • 资助金额:
    $ 33.99万
  • 项目类别:
CHEMICAL SYNTHESIS CORE
化学合成核心
  • 批准号:
    7384102
  • 财政年份:
    2007
  • 资助金额:
    $ 33.99万
  • 项目类别:

相似海外基金

Alcohol-induced epigenetic reprogramming of PPAR-α affects allopregnanolone biosynthesis
酒精诱导的 PPAR-α 表观遗传重编程影响异孕酮生物合成
  • 批准号:
    10658534
  • 财政年份:
    2023
  • 资助金额:
    $ 33.99万
  • 项目类别:
Progesterone and allopregnanolone of prefrontal cortical activity dynamics and heroin seeking
黄体酮和四氢孕酮对前额皮质活动动力学和海洛因寻求的影响
  • 批准号:
    10644613
  • 财政年份:
    2023
  • 资助金额:
    $ 33.99万
  • 项目类别:
Novel Intranasal Formulations of Allopregnanolone, a Regenerative Therapeutic for Alzheimer's Disease
Allopregnanolone 的新型鼻内制剂,一种阿尔茨海默病的再生疗法
  • 批准号:
    10698555
  • 财政年份:
    2023
  • 资助金额:
    $ 33.99万
  • 项目类别:
Using allopregnanolone to probe behavioral and neurobiological mechanisms that underlie depression in women across perimenopausal stage
使用四氢孕酮探讨围绝经期女性抑郁症的行为和神经生物学机制
  • 批准号:
    10557128
  • 财政年份:
    2022
  • 资助金额:
    $ 33.99万
  • 项目类别:
Allopregnanolone and Gamma-Aminobutyric Acid Receptor (GABA-A-R) Plasticity in Women with Premenstrual Mood Symptoms
四氢孕酮和 γ-氨基丁酸受体 (GABA-A-R) 可塑性对有经前情绪症状的女性
  • 批准号:
    10363837
  • 财政年份:
    2022
  • 资助金额:
    $ 33.99万
  • 项目类别:
Allopregnanolone and Gamma-Aminobutyric Acid Receptor (GABA-A-R) Plasticity in Women with Premenstrual Mood Symptoms
四氢孕酮和 γ-氨基丁酸受体 (GABA-A-R) 可塑性对有经前情绪症状的女性
  • 批准号:
    10619504
  • 财政年份:
    2022
  • 资助金额:
    $ 33.99万
  • 项目类别:
Clarifying the behavioural effect of allopregnanolone following long-term exposure to low levels.
阐明长期暴露于低水平的四氢孕酮对行为的影响。
  • 批准号:
    575829-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 33.99万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Using allopregnanolone to probe behavioral and neurobiological mechanisms that underlie depression in women across perimenopausal stage
使用四氢孕酮探讨围绝经期女性抑郁症的行为和神经生物学机制
  • 批准号:
    10358658
  • 财政年份:
    2022
  • 资助金额:
    $ 33.99万
  • 项目类别:
Allopregnanolone regulation of phasic dopamine release and motivated behavior
四氢孕酮对阶段性多巴胺释放和动机行为的调节
  • 批准号:
    10491710
  • 财政年份:
    2021
  • 资助金额:
    $ 33.99万
  • 项目类别:
Allopregnanolone regulation of phasic dopamine release and motivated behavior
四氢孕酮对阶段性多巴胺释放和动机行为的调节
  • 批准号:
    10314162
  • 财政年份:
    2021
  • 资助金额:
    $ 33.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了